Faculty Council Meeting & Town Hall

December 5, 2018 Agenda Section I – VP-Dean David Eidelman 1. Welcoming remarks 2. Approval of agenda 3. In memoriam Section II – David Eidelman 4. Report from the Steering Committee 5. Consent Agenda: Faculty Council minutes of September 26 6. Dean’s updates: Saudi situation, McGill Faculty of Medicine retreat and Powell Building update Section III 7. McGill Cancer Consortium (MC2): Dr. Morag Park 8. Bicentennial Planning: Dr. Gerald Cadet, Dr. Bernard Brais & Diana Colby, Mélanie Gauthier & Christina Kozakiewicz 9. Capital campaign: David Eidelman & Chantal Thomas (Postponed to Feb. meeting) Section IV 10. Provost and Vice-Principal Academic Christopher Manfredi Section V – David Eidelman 11. Kudos Section VI 12. Open session/Town Hall Agenda Section I – VP-Dean David Eidelman 1. Welcoming remarks 2. Approval of agenda 3. In memoriam Section II – David Eidelman 4. Report from the Steering Committee 5. Consent Agenda: Faculty Council minutes of September 26 6. Dean’s updates: Saudi situation, McGill Faculty of Medicine retreat and Powell Building update Section III 7. McGill Cancer Consortium (MC2): Dr. Morag Park 8. Bicentennial Planning: Dr. Gerald Cadet, Dr. Bernard Brais & Diana Colby, Mélanie Gauthier & Christina Kozakiewicz 9. Capital campaign: David Eidelman & Chantal Thomas (Postponed to Feb. meeting) Section IV 10. Provost and Vice-Principal Academic Christopher Manfredi Section V – David Eidelman 11. Kudos Section VI 12. Open session/Town Hall In Memoriam Margaret Becklake McGregor Depts. of Medicine & Epidemiology, Biostatistics and Occupational Health * Ralph Bilefsky Dept. of Medicine * Valentin Mbekou Dept. of Psychiatry * Ronald Yates Animal Resources Centre * Monique Lederman Integrated Program in Neuroscience * Peter Roughley Depts. of Surgery and Human Genetics Kudos

Order of Canada Inductees Dr. W. Dale Dauphinee Dr. Abraham Fuks Dr. Mitchell Halperin Dr. Yvonne Steinert

Royal Society of Canada Fellow Dr. Samy Suissa

Royal Society of Canada Member of the College of New Scholars, Artists and Scientists Dr. Nitika Pant Pai Kudos Abraham Flexner Award for Distinguished Service to Medical Education, Association of American Medical Colleges Dr. Sylvia Cruess and Dr. Richard Cruess

Canadian Academy of Health Sciences Elected Fellows Dr. James Mackay Brophy Dr. Julien Doyon Dr. Lily Hechtman Dr. Nada Jabado Dr. Mindy F. Levin Dr. Moshe Szyf Kudos

Principal’s Prize for Excellence in Teaching, Assistant Professor Category Dr. Nicole Li-Jessen

Principal’s Prize for Excellence in Teaching, Associate Professor Category Dr. David Ragsdale

Elected Chair, Board of Regents, American College of Surgeons Dr. Gerald Fried Kudos Named Site Director of Research, CISSS Laval Jewish Rehabilitation Hospital Dr. Aliki Thomas

Excellence in Nursing Research Award, Canadian Association of Schools of Nursing Dr. Nancy Feeley

Prix du Québec Wilder-Penfield Prize for Biomedical Research Dr. Nahum Sonenberg

Principal’s Awards for Administrative and Support Staff Rania Iliyan Neuro XXceptional team Kudos Canadian Women Leaders in Global Health, Canadian Society for International Health Dr. Amrita Daftary Dr. Christina Greenaway Dr. Theresa Gyorkos Dr. Catherine Hankins Dr. Srividya Iyer Dr. Nitika Pant Pai Dr. Argerie Tsimicalis Prof. Jodi Tuck Kudos

Maude Abbott Prize Dr. Aliki Thomas

Haile T. Debas Prize Dr. Sherif Emil

Rosemary Wedderburn Brown Prize Dr. Argerie Tsimicalis

Prix Jeune femme en sport, santé et mieux-être Women’s Y Foundation Dr. Emily McDonald Kudos Women of Distinction Laureate for Research and Innovation, Women’s Y Foundation Dr. Heidi McBride

Canada Research Chairs Dr. Sylvain Baillet Dr. Kolja Eppert Dr. Simon Gravel Dr. Irah L. King Dr. Mark G. Lathrop Dr. Anastasia Nijnik Dr. Daniela F. Quail Dr. Hamed Shateri Najafabadi Dr. Silvia Vidal Kudos

Appointed Member of the Commission sur les soins de fin de vie, Québec Council of ministers Dr. Eugene Bereza

International Lifetime Achievement Award, Mensa Foundation Dr. Brenda Milner

Top Professor of the Year in Nephrology, International Association of Top Professionals Dr. Raymond Hakim Kudos Family Medicine Researcher of the Year Award, College of Family Physicians of Canada Dr. Jeannie Haggerty

Justice Emmett Hall Laureate, Justice Emmett Hall Memorial Foundation -and- Peggy Leatt Award, University of Toronto’s Institute of Health Policy, Management and Evaluation Dr. Robyn Tamblyn

Honorary Scarlet Key from the McGill Alumni Association Dr. Pierre-Paul Tellier Kudos

Canadian Medical Hall of Fame inductee Dr. Rémi Quirion

Medicine Alumni Global Awards

Alumni Award of Merit from the McGill School of Communication Sciences & Disorders Dr. Areej Alasseri

Alumni Award of Merit, School of Physical & Occupational Therapy – Anelia Wright Kudos Medicine Alumni Global Awards (continued)

Young Alumni Award Dr. Horia Vulpe

Lifetime Achievement Award Dr. Joel Palefsky

Community Service Award Dr. Michael Viola

Alumni Award of Merit, Ingram School of Nursing Dr. Margaret Purden Kudos

Dean of Medicine Awards of Excellence (Ovation Awards)

Priyabrata “PB” Mukhopadhyay Award Johanne Bourdon

Anne McCormick Award, for the M classification Anna Lee

Pamela Chase Award, for the C classification Thomas Mills Kudos to Our Students Forces AVENIR Awards

Personnalité par Excellence Lahoud Touma

Projet par Excellence Aifred Health

Top honours, Health Category Intensive Care Unit Bridge Program Science & Technology category Dialysave Kudos to Our Students

Forces AVENIR (continued) Personnalité par Excellence finalist Emélie Sarah Elkrief

Finalist Community Health and Social Medicine Incubator

Outstanding Youth in Philanthropy Award, L’association des professionnels en philanthropie Olivia Monton

Congratulations to all! Report from Steering Committee At its November 5 meeting, the Steering Committee: • Approved the September 26 Faculty Council minutes (now online) • Approved today’s agenda • Welcomed new member, Dr. Ariane Marelli as the new CAS Clinical representative Consent Agenda

• Faculty Council September 26 minutes – Link was sent to FC members and Faculty-at-large following September 26 meeting – http://www.mcgill.ca/medicine/about/governance/faculty- council/meetings-minutes Dean’s Update Saudi Residents, Fellows, Students

• Kingdom of Saudi Arabia (KSA) decree in August 2018 • Since then, following individuals permitted to stay/return: – Saudi Medical trainees currently enrolled (residents, fellows) – New sponsored Saudi Medical trainees for Fall of 2018 and Winter and Spring of 2019 – Saudi Dentistry and Nursing trainees – Saudi Graduate students and Undergraduate students in final year of bachelor’s Ø Most students have now returned (an estimated 6 graduate students will not, along with 3 medical trainees) Dean’s Update McGill Faculty of Medicine Retreat • McGill academic health network retreat held Oct. 29, 2018 • Theme: “Learning in the clinical environment: How can we do it better?” • Co-organized by Faculty of Medicine, MUHC, CIUSSS- Centre-Ouest-de-l’Ile and CIUSSS-Ouest-de-l’Ile • Participants asked to reflect on three topics: o Learner wellness o Clinical supervision o Teaching performance and recognition • Ideas generated will be assessed by Learning Environment Action Panel, chaired by Annette Majnemer and including education leaders from the Faculty, MUHC and CIUSSSs Dean’s Update Powell Building – Status Report

• Project development is proceeding as planned • Dossier d’opportunité expected to be submitted to the government early in 2019 • Space for the 3 Basic Science departments proceeding well (Biomedical Engineering, Microbiology, Anatomy) • Space for laboratory teaching looking good • Also promising: space to create a crossroads joining upper and lower campus McGill Integrated Cancer Program Institute for Applied Cancer Science Achievements and Next Steps to Tackle Cancer Grand Challenges An update for Faculty of Medicine Retreat December 2017

MC2 McGill Integrated Cancer Consortium MC2 - Cancer Grand Challenges

Goals To leverage the power of fundamental, translational and clinical research for the detection, prevention, long-term management and cure of cancers.

Integrated Approach • build close integration of clinical practice with research • increase and harness clinical trials for discovery • develop multi- and interdisciplinary teams apply integrated systems approaches to understanding of disease - patient centric • harness the power of multi-omic big data • exploit clinical data through AI innovations-radiomics What would an Integrated Cancer Network accomplish?

Foster interdisciplinary multidisciplinary and inter-institutional research:

• Training programs: enhance and partner with departments and programs to develop interdisciplinary co-training models to serve as nodes • Seed grants: small one-time funding opportunities to bring together new teams to tackle priority areas • Shared platforms and harmonization: personnel support, resource sharing and strategic planning to maximize platform usefulness and lifespan • Secure large scale funding: early identification, project management and identification of co-funding for large scale initiatives (MESI, NCE, MESI, Terry Fox) Ongoing work and Next Steps

Cancer Summit • May 2018 Strategic plan development • Build our research teams and programs • Establish working groups from all pillars • Generate performance metrics and comparator data • Develop provincial, national and international partnerships

Establish next steps • Develop a governance plan • Define science, priority programs and vision • Determine our needs and draft a budget • Identify the role for donor support in a comprehensive funding plan What could a Grand Challenge Approach Accomplish

Patient Centric

Precision Therapy Prevention Diagnosis Metastasis 1 2 3 Therapies 4 Resistance 5

• Life Style Choices • Improved Non • Precision Oncology • Improved Detection • Chronic Invasive Approaches Inflammation • New therapies • Novel Therapies • Imaging • Obesity • Small molecule inhibitors • Tumor/stroma • Liquid Biopsies dependencies • Genetic • Antibody-based therapies Predisposition • Biomarkers • Metastatic niche • Immune therapies • Host immune • Novel Point of • Tumor evolution prevention Care Devices • Metabolic therapies

• Point of care • Epigenetic therapies devices MC2 • Emerging Research Focus Areas

Precision Oncology Big Data and Artificial Intelligence Translating Lifestyle Discoveries and into Prevention the Clinic MC2 Cancer Early Immunotherapy Cancer Drug Diagnosis Resistance and Metastatic Disease Cancer Grand Challenge Research Approach

unmet clinical need Surgical Clinical and Radiological Practice Tissue and Data Banks

Knowledge Cancer Basic and Translation and patient Translational Patient Impact population Research

>8,500 Partnerships with Industry Interdisciplinary Research for Target Validation and Drug Development Non FoM

Genomics/omics Big Data Sharing Platform Integration 30 Precision Oncology

Cancer diagnosis and treatment are changing Use of molecular-based profiling of individual patient’s tumor:

Optimize patient- Avoid predictably ineffective, Improve overall treatment matching toxic and costly treatments clinical outcomes

molecular pathology MC2 • Precision Oncology, Big Data and AI

MUHC Radiomics JGH

OncoDrive MUHC 600K digital pathology

MI4

Research Projects Microbiome

Data Warehouse MUHC/JGH/

Digital Pathology MUHC/JGH

Tissue Biobanking MUHC/JGH Platforms McGill Clinical Data Integration (national) JGH MUHC Personnel Recruitment Precision Oncology Funding Opportunities – Ongoing

Terry Fox Comprehensive Cancer Centre Network (PMH, BCCA) - Cancer Consortium (JGH, MUHC, CHUM, HMR, GCRC, IRIC) - Melanoma Network immunotherapy clinical trials - $6.2M/2yr Pilot Project Terry Fox Research Institute National Networks - (PYA) EPIC (Pancreatic) Multiple Myeloma

QCROC EXACTIS Ministère de l’Economie, Science et Innovation (MESI) (LOI Dec 2017) - MCC (MUHC, CHUM, JGH, HMR, GCRC, IRIC, LDI) $20M/4 yrs high burden and high fatality increase clinical trial recruitment

Oncopole EMC2 – Multi-institutional teams against cancer - Breast cancer – overcoming resistance - - 1.5M/3yrs Montreal Cancer Consortium

4 Large Cancer Hospitals (~17,000 cancer patients annually) Surgical Clinical and Radiological Practice Tissue and Data Banks

Knowledge Cancer Basic and Translation and patient Translational Patient Impact population Research

>17,000 Partnerships Interdisciplinary Research for Target Validation and Drug Development

Genomics/omics Big Data Sharing Platform Integration MC2 • Lifestyle and Prevention

Targeting obesity, metabolism and chronic GCRC inflammation in Cancer MUHC

Association lifestyle-related habits and cancer MUHC aggressiveness, treatment failure and progression.

Cancer prehabilitation: a perioperative opportunity to MUHC Research Projects influence recovery and cancer trajectory

MUHC Tissue Biobanking JGH McGill Clinical Data Integration MUHC JGH Mass Cytometry GCRC

GCRC Genomics MUHC

Platforms Metabolomics GCRC

Patient Metabolic Suites MUHC Big andData AI MRI Imaging and Analysis MUHC Personnel Recruitment MC2 • Early Cancer Diagnosis

Identification of Cancer-Promoting MUHC Aberrations $3M

3D Miniature Cancer-on-a-Chip and Early McGill Cancer Animal Models Engineering

Identification of Biomarkers Predictive of GCRC Research Projects Early Cancer Progression MUHC

Patients lifestyle habits tracking MUHC Tissue Biobanking MUHC Digital Pathology JGH McGill Clinical Data Integration MUHC Platforms

Mass Cytometry Big andData AI GCRC GCRC Genomics MUHC MC2 • Drug Resistance and Metastatic Disease

Targeting essential vulnerabilities in cancer cells Up to $20M to overcome drug resistance: McGill GCRC + 2M (GC for protein synthesis, tumor metabolism, epigenetics and MUHC immune surveillance DOSE)+765K+X Projects Research The role and function of exosomes in cancer GCRC MUHC metastasis. JGH

Genetic Perturbation and Viral Vector Engineering GCRC

MUHC Tissue Biobanking JGH McGill Centre for Exosome Nanomedicine bioengineering GCRC Patient Avatar Platform MUHC

Platforms Metabolomics GCRC GCRC Genomics MUHC

Mass Cytometry Big andData AI GCRC MC2 • Expanding the reach of Cancer Immunotherapy

Development of patient avatars that can be GCRC translated into clinical management of IIIA MUHC $ 6.5M NSCLC.

Discovery of biomarkers predictive of therapeutic GCRC response in melanoma patients. MUHC

GI and GU research (waiting for J. Spicer to get Research Projects GCRC back to me) MUHC Clinical Trial Enrollment JGH Tissue Biobanking MUHC MUHC Proteomics JGH Metabolomics GCRC Platforms GCRC Genomics MUGIQ

Mass Cytometry Big andData AI GCRC Recruitment with Mi4 Who could be partners at McGill?

Precision Therapy Prevention Diagnosis Metastasis 1 2 3 Therapies 4 Resistance 5

McGill Initiative in BioX McGill Interdisciplinary McGill Stem Cell and Computational Medicine Initiative in Infection Regenerative Medicine and Immunity (MI4)

Nanotechnology Inflammation Cancer stem cells Innovative devices Immune modulation Resistance Disruptive technologies Microbiome Technologies (IPS) Disruptive biologicals Fundraising – Need Partnership Approach

McGill University – Capital Campaign - funds raised can support Units at McGill that are contributing to a Cancer Grand Challenge – facilities for generation of data from clinical material

Motivated Donors Hospital Foundations - want to contribute to large - funds raised can support clinical research initiatives that trials and tissue banking include partnerships efforts – focused on a between McGill and Cancer Grand Challenge affiliated Hospitals

Other opportunities? MESI, Terry Fox, NCE, SPOR

Requires a strategy to highlight that funds are being raised jointly to tackle large scale projects that span the fundamental/clinical/translational continuum of cancer research Questions Montreal Cancer Consortium

4 Large Cancer Hospitals (~17,000 cancer patients annually) Surgical Clinical and Radiological Practice Tissue and Data Banks

Knowledge Cancer Basic and Translation and patient Translational Patient Impact population Research

>17,000 Partnerships Interdisciplinary Research for Target Validation and Drug Development

Genomics/omics Big Data Sharing Platform Integration Montreal Cancer Consortium

• MCC is a unique transformative Google Maps https://www.google.com/maps/@45.5190518,-73.6086191,12z collaboration bringing together the major McGill, GCRC, Genome Innovation Centre, MUHC, JGH, and U. de Montreal affiliated Institutes, CHUM, HMR and IRIC, to tackle cancer grand challenges.

• MCC groups : - 7 research centres, including - 4 university health centers - 150+ researchers, - 250+ clinicians, - 500+ trainees, - HQP in cores at each centre

Map data ©2018 Google 2 km

1 of 1 2018-05-29, 10:30 AM Precision Oncology

Cancer diagnosis and treatment are changing Use of molecular-based profiling of individual patient’s tumor:

Optimize patient- Avoid predictably ineffective, Improve overall treatment matching toxic and costly treatments clinical outcomes

Data Warehouse Digital Pathology Tissue Biobanking Platforms Clinical Data Integration (national) Personnel Recruitment MC2 • Emerging Themes

1) “Vulnerable Populations” -Modifiable risk factors for cancer prevention and management

2) Precision Oncology: Big Data: Research Accelerator

3) Drug Resistance and Metastatic Disease

4) Expanding the reach of Cancer Immunotherapies

5) Translating discoveries to cancer therapies

EPIC Multiple Melanoma (Pancreatic) Myeloma Network Current Challenge – the old model

Surgical Clinical and Radiological Practice Tissue and Data Banks

Knowledge Cancer Basic and Translation and patient Translational Patient Impact population Research

>8,500 Partnerships with Industry Interdisciplinary Research for Target Validation and Drug Development Non FoM

Genomics/omics Big Data Sharing Platform Integration 46 MC2 - Cancer Grand Challenges Goals To leverage the power of fundamental, translational and clinical research for the detection, prevention, long-term management and cure of cancers. Building on an Integrated Approach MC2 • build close integration of clinical practice with research • harmonize data warehouse-outcomes-across sites • increase and harness clinical trials for better patient outcomes and discovery • targeted tissue and liquid biopsy microbiome repositories for discovery and validation • develop multidisciplinary and interdisciplinary teams apply integrated systems approaches to understanding of disease - patient centric • harness the power of multi-omic big data • exploit clinical data through AI innovations-radiomics-digital pathology MC2 • Themes

1) Precision Oncology: Big Data: Research Accelerator

2) “Vulnerable Populations” -Modifiable risk factors for cancer prevention and management

3) Drug Resistance and Metastatic Disease

4) Expanding the reach of Cancer Immunotherapies

5) Translating discoveries to cancer therapies Surgery Care Team Radiation Therapy Surgery date Care team provider ID Diagnosis, Prescription Surgery type Care Team Member ID Treatment technique CPT code Care Team Member Role Imaging, DICOM RT & Dose, DVH Surgery notes Patient setup images and shifts Patient-reported outcomes Patient-reported outcomes Diagnosis Quality of life metric Diagnosis date Lab Results Diagnosis name data Procedure order record ID Diagnosis group Procedure order date etc infrastructure Result date Lab panel name (data lake) Line number of each component Medication Lab result component name Order record ID feature extraction, Value returned for result component Order date Medication name storage, machine Imaging (CT, PET, MRI, US) Medication order start/end date Procedure order record ID Medication admin dates learning, AI Procedure order date Patient-reported outcomes Pathology Procedure category name Procedure name Genetic Testing Procedure order record unique ID Procedure order date Visits Radiology notes Approved outside testing Procedure narrative Encounter unique ID Mutation Testing Encounter date Single gene test Procedure accession number Tumor type Reason for appointment Notes Tumor stage Visit notes Tumor grade MC2 • GCRC-Advanced Cancer Science Program

Mission Excellence Training Innovation Collaboration Objectives

Enable the Next Generation of Cancer Leaders Build an Integrated Technology Infrastructure

Recruit and retain highly skilled and diverse graduate Optimize current and develop new cutting-edge students, post-doctoral fellows and clinical fellows technology platforms

Engage in strategic interdisciplinary and intersectoral Facilitate interdisciplinary and intersectoral training collaborations

Implement knowledge translation strategies to explore Ensure skill growth and leadership development commercialization opportunities MICAS Training Program and GCRC-ACS Platforms

Oncology Big Data Engineering Fundamental Ethics Commercialization Metabolomics Image Analytics Nanotechnologies Translational Science Policy Entrepreneurship Mass Cytometry Artificial Intelligence Material Sciences Clinical Precision Oncology

Cancer diagnosis and treatment are changing Use of molecular-based profiling of individual patient’s tumor:

Optimize patient- Avoid predictably ineffective, Improve overall treatment matching toxic and costly treatments clinical outcomes

molecular pathology - Pediatric Cancer Grand Challenge unmet clinical need Pediatric Cancers

Biospecimen

Cancer Molecular Profiling Biobank & & Personalized Data Models Treatment Repository of Cancers Clinical Efficacy of Trials Precision Medicine

• Discover New Targets IMPROVE OUTCOMES • Validate Targets FOR PEDIATRIC • Develop Therapies CANCERS Nada Jabado • Understand Biology MUHC 52 Program Overview Melanoma Network-Grand Challenge

Study Timing Location/Investigator # Patients Immune checkpoint inhibitor studies

A randomized Phase II study of Ipilimumab with or without 2012-15 JGH: W. Miller; A Spatz; L. Van Phase II carboplatin and paclitaxel in patients with unresectable Kempen ; CHUM: R. Lapointe; R. 31 patients Stage III or Stage IV Melanoma (BMS) Jamal.

A Phase I/II Study of Pembrolizumab in Combination with 2016-18 CHUM: N. Blais; PO Gaudreau, R. Phase I/II Nab-Paclitaxel in Patients with Unresectable Stage III or Lapointe; J. Stagg; D Kaufmann; 36 Patients Stage IV Non Small-Cell Lung Carcinoma (Merck) JGH: W. Miller.

A Phase II study of pembrolizumab with 2016-18 JGH: W. Miller; A Spatz; L. Van Phase II carboplatin/paclitaxel in patients with metastatic melanoma Kempen ; CHUM: R. Lapointe; R. 54 Patients Réjean Lapointe (Merck) Jamal. Case series: Molecular determinants of response to anti- Ongoing MUHC: C. Mihalcioiu, S. Meterissian, 42 patients CTLA-4 and anti-PD-1 in melanoma K.Watters; JGH: W. Miller; A Spatz; L. Van Kempen; CHUM: R. Jamal; GCRC: I. Watson, P. Siegel.

John Stagg

Rahima Jamal Wilson Miller Alan Spatz Leon Van Kempen Catalin Mihalcioiu Sarkis Meterissian Ian Watson Peter Siegel McGill University

BICENTENNIAL CELEBRATIONS

Sept. 2020 – Dec. 2021

December 2018 Bicentennial vision

For 200 years McGill has been a beacon of knowledge and transformation in Montreal, Quebec, Canada, and the World. Over the next 100 years, we will continue shaping our world and inspire new generations of students and educators.

55 Bicentennial goals

Celebrate milestone anniversary

Engage all our community

Create a shared vision of McGill’s future

Launch our third century

Reinforce the University’s strategic priorities through the programming

Show how McGill has evolved and will continue to evolve

56 Faculties' planning process

Selection of Each Faculty Faculty Possibility of limited number created own committee special event(s) Final plans: of regular bicentennial responsible for and/or events to be 1st half 2019 committee planning project(s) branded

57 Additional initiatives

Research: today and tomorrow VP R&I Student outreach Bicentennial office & DPSLL International programming AP International & VP CER Indigenous programming Special advisor, Indigenous initiatives History of McGill Bicentennial office Equity and diversity AP Equity & Academic policies

Alumni-related local and international events – UA

Sustainable McGill Office of Sustainability 58 Signature Projects

59 Bicentennial launch – Homecoming 2020 weekend Dates: 24-26 September 2020

Events: 24 Sept. 2020|Launch ceremony & immersive show Official opening & musical performances Immersive light show at & Arts bldg. throughout Bicentennial and beyond • Location: Lower field east, Roddick Gates, Arts bldg.

25 sept. 2020|Rhodes scholars’ Reunion Breakfast and discussion with scholars • Scholars’ participation in Faculty Homecomings • Location: and

Selected regular Homecoming events|TBD with UA 60 Bicentennial Staff celebration

Date: June 2021, after Convocation

Event: Celebrating the contributions of McGill employees (faculty, administrative & support staff), past and present • Musical entertainment, various activities • Employee recognition • Food and drinks

Location: Lower Field – Convocation tent

61 McGill, Space and aerospace

Date: 28-29 Sept. 2021 • McGill's five astronauts as 2021 Beatty Lecture • Two day conference - McGill faculty & researchers ü McGill Space Institute ü McGill Institute of Air & Space Law ü McGill Institute for Aerospace Engineering ü Faculty of Medicine • Potential exhibition of space-related material • Potential collaboration with Canadian Space Agency

Location(s): • Downtown campus • Place des Arts (tentative)

62 Key success markers

Ø Great student, faculty, and staff participation Ø Strong alumni engagement Ø Lasting legacies created Ø Well attended signature projects Ø Broad range of events in Faculties Ø Improved results in various areas of Montrealers’ and Quebecers’ perception of McGill

10 Celebrating the Bicentennial in the Faculty Sept. 2020 – Dec. 2021 Why celebrate?

• Big milestone for McGill’s 1st faculty and Canada’s 1st faculty of medicine – We deserve to celebrate! • Moment to reflect on our contributions and evolution, locally and globally • Opportunity to look forward to our 3rd century in education, research and care Not just “Medicine”

• It’s the Ingram School of Nursing’s 100th • It’s the Montreal General Hospital’s 200th – Our histories are inextricably linked

66 Who do we celebrate with?

Internal Alumni & donors External Academics MGH Montreal & Learners, Staff MUHC RUIS communities, McGill at large CIUSSS du Centre-Ouest Canadian & Int’l CIUSSS de l’Ouest communities RUIS partners

67 How do we celebrate?

• Highlight past, with strong focus on future • Interprofessionally • Engage academics, learners, staff, alumni, our communities • Wow factor… • Meaningful from a mission perspective • Other?

68 Volunteer Committee

• Academic lead: Bernard Brais – Professor of Neurology and Human Genetics – Trained Medical Historian – Interest manifested by approximately 40 volunteers from across the Faculty who took part in two consultation meetings

69 Emerging ideas & themes

• Holmes Lecture Series 200 (future-focused) • Brand major high-profile symposiums, conferences and events – e.g., Nursing Explorations, Palliative Care conference, etc. • Contribute to Montreal General Hospital’s celebratory events • “200 years, 200 stories...”

70 Celebrate the social contributions of the Faculty and MGH • The McGill Faculty and its affiliated hospitals have always contributed to large humanitarian efforts such as the Great World Wars, international and Northern Quebec health development ventures, etc. In the context of the 200th of McGill we thought that a major event with possible associated exhibits and talks could celebrate those great social contributions.

Baroness Burdett-Coutts’ Garden Party 71 Building capacity to save lives (CPR, defrib demos & workshops) • Celebrate in a way that reflects our mission – education, research, social commitment • Target external, while engaging internal communities • Interprofessional teams, incl. academics, learners and staff • Demos & workshops at targeted RUIS McGill sites: – On campus – MUHC – CIUSSS du Centre-Ouest – CIUSSS de l’Ouest – CISSS Outaoauis – Other key sites in our RUIS • Format: Demos in public places (e.g., malls), with option to sign up for workshops at discount price, or free(?) • “Your heart to heart / Votre cœur nous tient à cœur” 72 More ideas & themes…

• Historical website and interactive timeline – 200 years, 200 stories (from Faculty and alums) – History book? Coffee table book? • “Then and Now” photo campaign with alumni • Major social media campaigning (int’l) • Open house events, e.g., Simulation Centre • Lab roadshows, to showcase science • Children-focused activities • McGill “Innovation Trail,” tourist attraction, virtually or physically, sustainable after the event, with time capsules

73 Short List? (Framed by our tripartite mission)

Internal Teaching hospitals External (Academics, staff, & networks, (Mtl, RUIS, Canada, learners, McGill) Alumni & donors International) • Holmes 200 • Major event to • Historical series celebrate social interactive • … contributions, timeline/Social e.g. with MGH media • … campaign • Building capacity to save lives…

74 Next step?

• Input from Faculty Council • Finalize short list, considering cost and feasibility • Create formal Bicentennial Committee and subcommittees • Call for major Faculty firsts/contributions, unsung staff heroes • Flag events with an International, Indigenous, or Equity/diversity component • Find $$$s • Get to work! 75 Celebrating 100 Years of McGill Nursing Overview of planning, goals and more, in preparation for the Ingram School of Nursing’s Centennial Anniversary

Presented on December 5, 2018, by: Mélanie Gauthier, Faculty Lecturer, Centennial Committee Co-Chair, Ingram School of Nursing Christina Kozakiewicz, Communications Officer, Ingram School of Nursing Why celebrate?

• Storied history of resilience and innovation worthy of celebration and recognition

• Celebrate nurses and the nursing profession

• Need to acknowledge many different stakeholders

• Moment to reflect on our contributions and evolution, locally and globally

• Opportunity to set the stage for our 2nd century in education, research and care Who do we celebrate with?

• Academics, Learners, Staff, Faculty of Medicine, McGill at large • Alumni, donors, and potential donors • RUIS and McGill Teaching Hospital Network • Community Organizations and other clinical partners • Associations and other Schools of Nursing • CEGEP consortium • Nurses in practice How do we go about it?

• Highlight past, but with strong focus on future • Focus on what sets us apart and defines us: Strengths-Based Nursing Approach to Care • Focus on activities that highlight education, research and service • Stay tuned into Faculty of Medicine and McGill Bicentennial plans and campaign • Celebrate throughout 2020 – starting in January and ending in November Volunteer Committee

• 2017: Centennial Steering Committee established • Composed of faculty members, administrative staff, alumni, clinical partners • Project Charter developed with progress reporting structure

Work groups established: ü Educational/Research Activities ü Communications & Marketing ü Celebrations (Gala) ü Legacy ü Sponsorship Emerging ideas & themes

• 100 Stories of Strengths campaign, potential launch International Nurses Day May 12, 2019: - Whisper campaign to begin promotion May-December 2019 - Digital storytelling campaign January-November 2020 • 2020 Nursing Explorations Conference November 20, 2020 • Gala event to close the year Next steps?

Timeline, deliverables and budget for each work group Questions?

Thank you! Open Discussion/Town Hall

and… www.mcgill.ca/medicine/about/governance/faculty-council/topicscomments-questions Please hand in your name cards!